Reneo Pharmaceuticals Ownership | Who Owns Reneo Pharmaceuticals?

Overview Forecast RevenueFinancials Chart

Reneo Pharmaceuticals Ownership Summary

Reneo Pharmaceuticals is owned by 81.62% institutional investors, 5.19% insiders, and 13.19% retail investors. Nea management company is the largest institutional shareholder, holding 14.32% of RPHM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 17.83% of its assets in Reneo Pharmaceuticals shares.

RPHM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Reneo Pharmaceuticals	81.62%	5.19%	13.19%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Nea management company	4.79M	14.32%	$7.23M
Tang capital management	3.00M	8.97%	$4.52M
Highbridge capital management	2.92M	8.72%	$4.40M
Carlyle group	2.70M	8.08%	$4.16M
Bml capital management	2.67M	8.00%	$4.04M
Rivervest venture management	2.53M	7.58%	$3.83M
Octagon capital advisors lp	2.25M	6.73%	$3.40M
Aisling capital management lp	886.08K	2.65%	$1.34M
Vanguard group	882.10K	2.64%	$1.33M
Nantahala capital management	547.80K	1.64%	$846.36K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rivervest venture management	2.53M	56.07%	$3.83M
Bml capital management	2.67M	2.88%	$4.04M
Aldebaran capital	447.62K	0.63%	$675.90K
Aisling capital management lp	886.08K	0.58%	$1.34M
Nea management company	4.79M	0.54%	$7.23M
Octagon capital advisors lp	2.25M	0.53%	$3.40M
Tang capital management	3.00M	0.46%	$4.52M
Carlyle group	2.70M	0.39%	$4.16M
Acuitas investments	406.21K	0.33%	$613.38K
Highbridge capital management	2.92M	0.14%	$4.40M

Top Buyers

Holder	Shares	% Assets	Change
Nantahala capital management	547.80K	0.05%	547.80K
Bml capital management	2.67M	2.88%	494.28K
Vestal point capital, lp	545.00K	0.06%	249.63K
Highbridge capital management	2.92M	0.14%	178.81K
Millennium management	109.99K	0.00%	109.99K

Top Sellers

Holder	Shares	% Assets	Change
Rock springs capital management lp	-	-	-751.73K
Blackrock	293.65K	-	-700.01K
State street	71.64K	-	-175.79K
Opaleye management	-	-	-165.00K
Renaissance	442.20K	0.00%	-151.09K

New Positions

Holder	Shares	% Assets	Change	Value
Nantahala capital management	547.80K	0.05%	547.80K	$846.36K
Squarepoint ops	19.49K	-	19.49K	$29.43K
Point72 asia (singapore) pte.	18.03K	0.01%	18.03K	$27.22K
Aqr capital management	10.40K	-	10.40K	$15.71K
Mirae asset global investments	998.00	-	998.00	$1.61K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-2.00
Nisa investment advisors	-40.00
Advisor group	-41.00
Farther finance advisors	-117.00
Amalgamated bank	-327.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	62	-6.06%	27,277,054	-0.32%	81	1.25%	32	14.29%	19	-
Mar 31, 2024	66	-15.38%	27,363,476	8.32%	80	1.45%	28	-40.43%	19	18.75%
Dec 31, 2023	78	32.20%	25,262,300	-7.60%	74	0.91%	47	46.88%	16	23.08%
Sep 30, 2023	59	15.69%	27,339,727	4.28%	90	0.83%	32	-17.95%	13	160.00%
Jun 30, 2023	51	50.00%	26,216,540	53.62%	104	2.25%	39	143.75%	5	-28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	596.11K	17.83%	-
Vanguard Institutional Extnd Mkt Idx Tr	278.54K	8.33%	-
iShares Biotechnology ETF	145.72K	4.36%	280.00
iShares Micro-Cap ETF	46.47K	1.39%	-
NT R2000 Index Fund - NL	35.07K	1.05%	-138.00
NT R2000 Index Fund - DC - NL - 2	27.75K	0.83%	-208.00
NT R2000 Growth Index Fund - NL	26.00K	0.78%	-
iShares Nasdaq US Biotech ETF USD Acc	23.21K	0.69%	-
The Vanguard Russell 2000 Growth Index	13.69K	0.41%	-
Northern Trust Russell 2000 Growth Index	13.35K	0.40%	-5.92K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 24, 2024	Leonard Braden Michael	-	Buy	$41.87K
Sep 25, 2024	Leonard Braden Michael	-	Buy	$102.87K
Sep 18, 2024	Leonard Braden Michael	-	Buy	$1.13K
Sep 17, 2024	Leonard Braden Michael	-	Buy	$75.11K
Sep 16, 2024	Leonard Braden Michael	-	Buy	$236.87K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	9	-
2024 Q2	2	-
2023 Q3	-	1
2023 Q2	1	1
2022 Q4	-	-

RPHM Ownership FAQ

Who Owns Reneo Pharmaceuticals?

Reneo Pharmaceuticals shareholders are primarily institutional investors at 81.62%, followed by 5.19% insiders and 13.19% retail investors. The average institutional ownership in Reneo Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Reneo Pharmaceuticals exceeds.

Who owns the most shares of Reneo Pharmaceuticals?

Reneo Pharmaceuticals’s largest shareholders are Nea management company (4.79M shares, 14.32%), Tang capital management (3M shares, 8.97%), and Highbridge capital management (2.92M shares, 8.72%). Together, they hold 32.01% of Reneo Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reneo Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Reneo Pharmaceuticals.

Who is Reneo Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Rivervest venture management is Reneo Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 56.07% of its assets in 2.53M Reneo Pharmaceuticals shares, valued at 3.83M$.

Who is the top mutual fund holder of Reneo Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Reneo Pharmaceuticals shares, with 17.83% of its total shares outstanding invested in 596.11K Reneo Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools